Choosing the Appropriate Intervention for Symptomatic and Asymptomatic Carotid Disease in the Era of Multiple Therapies: Integration of Risk Profile and Technical Data

Seminars in Vascular Surgery

Volumn 24, Issue 1, 2011, Pages 53-59

  Shrikhande, Gautam V ^a   McKinsey, James F ^a  

^a Columbia University Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGING; ARTICLE; ASYMPTOMATIC DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL STUDY; EMBOLIC PROTECTION DEVICE; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGE FACTORS; ANGIOPLASTY; ASYMPTOMATIC DISEASES; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 79959582979     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2011.03.006     Document Type: Article

References (42)

1. Kochanek K.D., Murphy S.L., Anderson R.N., Scott C. Deaths: final data for 2002. Natl Vital Stat Rep 2004, 53:1-115.
2. Place of death after stroke-United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2006, 55:529-532. Centers for Disease Control and Prevention.
3. Eastcott H.H.G., Pickering G.W., Rob C.G. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954, 264:994-996.
4. Mathias K. A new catheter system for percutaneous transluminal angioplasty (PTA) of carotid artery stenoses. Fortschr Med 1977, 95:1007-1011.
5. Mathias K., Mittermayer C.H., Ensinger H., et al. Percutaneous catheter dilatation of carotid stenoses. Rofo 1980, 133:258-261.
6. Kerber C.W., Cromwell L.D., Loehden O.L. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradio 1980, 1:348-349.
7. Hobson R.W., Mackey W.C., Ascher E., et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society of Vascular Surgery. J Vasc Surg 2008, 48:480-486.
8. Brott T.G., Hobson R.W., Howard G., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010, 363:11-23.
9. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomized controlled trial. Lancet 2010, 375:985-997. International Carotid Stenting Study Investigators.
10. Schneider P.A., Naylor A.R. Asymptomatic carotid artery stenosis-medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. J Vasc Surg 2010, 52:499-507.
11. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273:1421-1429.
12. Rockman C., Riles T. Carotid artery disease: selecting the appropriate asymptomatic patient for intervention. Perspect Vasc Surg Endovasc Ther 2010, 22:30-37.
13. Yamada K., Yoshimura S., Kawasaki M., et al. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization or carotid atherosclerotic plaques with integrated backscatter ultrasound. Cerebrovasc Dis 2009, 28:417-424.
14. Mercuri M., Bond M.G., Sirtori C.R., et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 1996, 101:627-634.
15. Hodis H.N., Mack W.J., LaBree L., et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996, 124:548-560.
16. MacMahon S., Sharpe N., Gamble G., et al. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. Circulation 1998, 97:1784-1790.
17. Youssef F., Seifalian A.M., Jagroop I.A., et al. The early effect of lipid lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg 2002, 23:358-364.
18. Spence J.D., Coates V., Li H., Tamayo A., et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 2010, 67:180-186.
19. Rockman C.B., Riles T.S., Lamparello P.J., et al. Natural history and management of the asymptomatic, moderately stenotic internal carotid artery. J Vasc Surg 1997, 25:423-431.
20. Halliday A., Harrison M., Hayter E., et al. 10-year stroke prevention after a successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicenter randomized trial. Lancet 2010, 376:1074-1084.
21. Gray W.A., Hopkins L.N., Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006, 44:258-269.
22. Fairman R., Gray W.A., Scicli A.P., et al. The CAPTURE Registry: analysis of strokes resulting from carotid artery stenting in the post-approval setting: timing, location, severity and type. Ann Surg 2007, 246:551-558.
23. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004, 351:1493-1501.
24. Sacco R.L., Adams R., Albers G., et al. Guidelines for the prevention of stroke in patients with ischaemic stroke or transient ischaemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:577-617.
25. Rudarakanchana N., Dialynas M., Halliday A. Asymptomatic Carotid Surgery Trial-2 (ACST-2): rationale for a randomized clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with asymptomatic carotid artery stenosis. Eur J Vasc Endovasc Surg 2009, 38:239-242.
26. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991, 325:445-453. North American Symptomatic Carotid Endarterectomy Trial Collaborators.
27. Barnett H.J., Taylor D.W., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998, 339:1415-1425.
28. MRC European Carotid Surgery trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991, 337:1235-1243. European Carotid Surgery Trialists' Collaborative Group.
29. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998, 351:1379-1387. MRC European Carotid Surgery Trialists.
30. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 2001, 357:1729-1737.
31. Ederle J., Bonati L.H., Dobson J., et al. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow up of a randomized trial. Lancet Neurol 2009, 8:898-907.
32. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006, 355:1660-1671.
33. Ringleb P.A., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet 2006, 368:1239-1247.
34. Eckstein H.H., Ringleb P., Allenberg J.R., et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenosis at 2 years: a multinational, prospective, randomized trial. Lancet Neurol 2008, 7:893-902.
35. Ansel G.M., Hopkins L.N., Jaff M.R., et al. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 2010, 76:1-8.
36. Clair D.G., Hopkins L.N., Mehta M., et al. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE clinical study. Catheter Cardiovasc Interv 2011, 77:420-429.
37. Percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stenting. MLN Matters MM6839 Centers for Medicare and Medicaid Services, Accessed February 7, 2011. http://www.cms.gov/MLNMattersArticles/downloads/MM6839.pdf.
38. Nguyen L.L., Conte M.S., Reed A.B., et al. Carotid endarterectomy: who is the high-risk patient?. Semin Vasc Surg 2004, 17:219-223.
39. Mozes G., Sullivan T.M., Torres-Russotto D.R., et al. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: Implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg 2004, 39:958-966.
40. Gurm H.S., Yadav J.S., Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008, 359:1572-1579.
41. Bonati L.H., Dobson J., Algra A., et al. Short-term outcomes after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010, 376:1062-1073.
42. Bowens N.M., Fairman R.M. Carotid artery stenting: clinical trials and registry data. Semin Vasc Surg 2010, 23:148-155.